DSM Integrated Annual Report 2021

Nutrition performance 2021

Highlights 2021

Nutrition delivered a very good performance, with 8% volume-driven organic growth. This business cluster demonstrated its superior operational performance and reliability as a supplier as it successfully navigated significant supply chain and logistical disruptions that affected the market throughout the year, strengthening its customer relationships in the process. A 4% contribution from acquisitions, offset by a 2% negative foreign exchange effect, led to a 10% increase in total sales in 2021.

Nutrition reported 8% growth in Adjusted EBITDA largely related to increased volumes, with a 6% contribution from acquisitions and a 4% negative foreign exchange effect. The Adjusted EBITDA margin of 20.6% was slightly down compared to 2020 (21.0%), reflecting some inflationary cost effects toward the end of the year.

x € million

 

2021

 

2020

 

 

 

 

 

Net sales from continuing operations:

 

 

 

 

DSM Nutritional Products:

 

 

 

 

- Animal Nutrition & Health

 

3,502

 

3,025

- Human Nutrition & Health

 

2,207

 

2,143

- Personal Care & Aroma Ingredients

 

484

 

404

- Other1

 

122

 

145

Total DSM Nutritional Products

 

6,315

 

5,717

 

 

 

 

 

DSM Food Specialties

 

716

 

648

Total Nutrition

 

7,031

 

6,365

 

 

 

 

 

Organic sales growth (in %)

 

8

 

6

Adjusted EBITDA

 

1,447

 

1,338

Adjusted operating profit

 

940

 

919

Capital expenditure

 

488

 

441

Capital employed at 31 December

 

9,550

 

8,305

ROCE (in %)

 

10.6

 

12.6

Adjusted EBITDA margin (in %)

 

20.6

 

21.0

R&D expenditure

 

257

 

241

Workforce at 31 December (headcount)

 

16,091

 

15,838

1

‘Other’ covers pharma and custom manufacturing & services activities.

Net sales bridge 2021

x € million

Net sales bridge nutrition (waterfall chart)

"Our nutrition business made significant progress in 2021 in terms of both operational performance and the acceleration of our strategic journey. Core to this are our exciting innovation platforms that help drive health for people and planet."

Dimitri de Vreeze, Co-CEO, Royal DSM
Earnings before interest, tax, depreciation and amortization (EBITDA)
EBITDA is the sum of operating profit plus depreciation and amortization. Adjusted EBITDA is the EBITDA adjusted for material items of profit or loss coming from acquisitions/divestments, restructuring and other circumstances that management deem it necessary to adjust in order to provide clear reporting on the development of the business.